These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36207727)

  • 1. Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey.
    Ameyaw EK
    Malar J; 2022 Oct; 21(1):285. PubMed ID: 36207727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is improvement in indicators of women's empowerment associated with uptake of WHO recommended IPTp-SP levels in sub-Saharan Africa? A multilevel approach.
    Ameyaw EK; Njue C; Amoah RM; Appiah F; Baatiema L; Ahinkorah BO; Seidu AA; Ganle JK; Yaya S
    BMJ Open; 2021 Oct; 11(10):e047606. PubMed ID: 34716158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda.
    Kiwuwa MS; Mufubenga P
    Malar J; 2008 Mar; 7():44. PubMed ID: 18312682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.
    Mutanyi JA; Onguru DO; Ogolla SO; Adipo LB
    Infect Dis Poverty; 2021 Aug; 10(1):106. PubMed ID: 34362443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.